By suppressing this pathway through PTP1b inhibition, researchers identified a reduction in migration, invasion, and proliferation in glioblastoma-multiforme (GBM), colorectal cancer, and ovarian cancer cell lines [31]. Here, PTPN1 is linked to ovarian carcinoma.